Crystal structure of the Pseudomonas aeruginosa MurG: UDP-GlcNAc substrate complex

Protein and Peptide Letters

Volumn 20, Issue 9, 2013, Pages 1002-1008

  Brown, Kieron ^a   Vial, Sarah C M ^a   Dedi, Neesha ^a   Westcott, James ^a   Scally, Stephen ^a,c   Bugg, Timothy D H ^b   Charlton, Peter A ^a   Cheetham, Graham M T ^a  

^a VERTEX PHARMACEUTICALS   (United States)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Enzymology; Fluorimetry; Peptidoglycan biosynthesis; Transferase; X ray crystallography

Indexed keywords

GLUCOSYLTRANSFERASE; LIPID; LIPID 1; PROTEIN MURG; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CARBOHYDRATE TRANSPORT; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME MECHANISM; ENZYME PURIFICATION; ENZYME SUBSTRATE; ENZYME SUBSTRATE COMPLEX; MOLECULAR PATHOLOGY; NONHUMAN; PROTEIN FUNCTION; PROTEOGLYCAN SYNTHESIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SOLUBILIZATION;

EID: 84882350101     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929866511320090006     Document Type: Article

References (34)

1. van Eldere J. Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections. J. Antimicrob. Chemother., 2003, 51, 347-52.
2. Poole K Efflux-mediated multiresistance in Gram-negative bacteria. Clin. Microbiol. Infect., 2004, 10, 12-26.
3. Balcht AL, Smith RP Pseudomonas Aeruginosa: Infections and Treatment. Informa. Health Care, 1994, pp 83-84.
4. Davies JC Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence. Paediatr. Respir. Rev., 2002, 3, 128-34.
5. Mendelson MH, Gurtman A, Szabo S, Neibart E, Meyers BR, Policar M, Cheung TW, Lillienfeld D, Hammer G, Reddy S, et al. Pseudomonas aeruginosa bacteremia in patients with AIDS. Clin. Infect. Dis., 1994, 18, 886-95.
6. Cunha BA Pseudomonas aeruginosa: resistance and therapy. Semin. Respir. Infect., 2002, 17, 231-9.
7. Spratt BG Resistance to antibiotics mediated by target alterations. Science, 1994, 264, 388-93.
8. Katz AH, Caufield CE. Structure-based design approaches to cell wall biosynthesis inhibitors. Curr. Pharm. Des., 2003, 9, 857-866.
9. El Zoeiby A, Sanschagrin F, Levesque RC Structure and function of the Mur enzymes: development of novel inhibitors. Mol. Microbiol., 2003, 47, 1-12.
10. Bugg TDH, Walsh CT Intracellular steps of bacterial cell wall peptidoglycan biosynthesis: Enzymology, antibiotics, and antibiotic resistance. Nat. Prod. Rep., 1992, 199-215.
11. Turk S, Kovac A, Boniface A, Bostock JM, Chopra I, Blanot D, Gobec S. Discovery of new inhibitors of the bacterial peptidoglycan biosynthesis enzymes MurD and MurF by structure-based virtual screening. Bioorg. Med. Chem., 2009, 17, 1884-9.
12. Kotnik M, Anderluh PS, Prezelj A Development of novel inhibitors targeting intracellular steps of peptidoglycan biosynthesis. Curr. Pharm. Des., 2007, 13, 2283-309.
13. Silver LL Does the cell wall of bacteria remain a viable source of targets for novel antibiotics? Biochem. Pharmacol., 2006, 71, 996-1005.
14. Lovering A, de Castro L, Lim D, Strynadka N Structural insight into the transglycosylation step of bacterial cell-wall biosynthesis. Science, 2007, 315, 1402-5.
15. Men H, Park P, Ge M, Walker S Substrate Synthesis and Activity Assay for MurG. J. Am. Chem. Soc., 1998, 120, 2484-2485.
16. Trunkfield AE, Gurcha SS, Besra GS, Bugg TD Inhibition of Escherichia coli glycosyltransferase MurG and Mycobacterium tuberculosis Gal transferase by uridine-linked transition state mimics. Bioorg. Med. Chem., 2010, 18, 2651-63.
17. Salmond GPC, Lutkenhaus JF, Donachie WD Identification of new genes in a cell envelope-cell division gene cluster of Escherichia coli: cell envelope gene MurG. J. Bacteriol., 1980, 144, 438-440.
18. Mengin-Lecreulx D, Texier L, Rousseau M, van Heijenoort J The murG gene of Escherichia coli codes for the UDP.-Nacetylglucosamine: N.-Acetylmuramyl- (pentapeptide) pyrophosphoryl-undecaprenol Nacetylglucosamine transferase involved in the membrane steps of peptidoglycan synthesis. J. Bacteriol., 1991, 173, 4625-36.
19. Barbosa, MD, Ross HO, Hillman MC, Meade RP, Kurilla MG, and Pompliano DL A multitarget assay for inhibitors of membraneassociated steps of peptidoglycan biosynthesis. Anal. Biochem., 2002, 306, 17-22.
20. Lo M.-C, Men H, Branstrom A, Helm J, Yao N, Goldman R, Walker S A new mechanism of action proposed for ramoplanin. J. Am. Chem. Soc., 2000, 122, 3540-3541.
21. Ha S, Walker D, Shi Y, Walker S The 1.9 A crystal structure of Escherichia coli MurG, a membrane-Associated glycosyltransferase involved in peptidoglycan biosynthesis. Protein Sci., 2000, 9, 1045-52.
22. Hu Y., Chen L., Ha S., Gross B., Falcone B., Walker D., Mokhtarzadeh M., Walker S. Crystal structure of the MurG:UDP.-GlcNAc complex reveals common structural principles of a superfamily of glycosyltransferases PNAS, 2003, 100, 845-9.
23. Leslie, AGW Recent changes to the MOSFLM package for processing film and image plate data. Joint CCP4 and ESF.-EACMB Newsletter on Protein Crystallography 1992 (Daresbury Laboratory, Warrington, UK).
24. Evans P Scaling and assessment of data quality. Acta Crystallogr. D Biol. Crystallogr., 2006, 62, 72-82.
25. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RC Phaser crystallographic software. J. Appl. Cryst., 2000, 40, 658-674.
26. Roversi, P, Blanc, E, Vonrhein, C, Evans, G, Bricogne, G Modelling prior distributions of atoms for Macromolecular Refinement and Completion. Acta Cryst. D Biol. Crystallogr., 2000, 56, 1313-1323.
27. Blanc, E, Roversi, P, Vonrhein, C, Flensburg, C, Lea, SM, Bricogne, G Refinement of severely incomplete structures with maximum likelihood in BUSTER.-TNT. Acta Cryst. D Biol. Crystallogr., 2004, 60, 2210-2221.
28. Emsley P, Lohkamp B, Scott W, Cowtan K. Features and Development of Coot. Acta Crystallogr. D Biol. Crystallogr., 2010, 66, 486-501.
29. Ha S, Chang E, Lo M.-C, Men H, Park P, Ge M, Walker S. The kinetic characterization of Escherichia coli MurG using synthetic substrate analogues. J. Am. Chem. Soc., 1999, 121, 8415-8426.
30. Chen L, Men H, Ha S, Ye X.-Y, Brunner L, Hu Y, Walker S Intrinsic Lipid Preferences and Kinetic Mechanism of Escherichia coli MurG. Biochemistry, 2002, 41, 6824-6833.
31. Carugo O, Argos P. NADP.-dependent enzymes. I: Conserved stereochemistry of cofactor binding. Proteins, 1997, 28, 10-28.
32. Krissinel E, Henrick K Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Cryst. D Biol. Crystallogr., 2004, 60, 2256-2268.
33. Crouvoisier M, Auger G, Blanot D, Mengin-Lecreulx D Role of the amino acid invariants in the active site of MurG as evaluated by site-direct mutagenesis. Biochemie, 2007, 89, 1498-1508.
34. The PyMOL Molecular Graphics System, Version 1.3, Schrödinger, LLC.